Ascend Capital Partners successfully sells Grundium Oy to EW Healthcare Partners, marking a significant exit that reinforces Ascend's commitment to investing in European healthcare technology.
Target Information
Grundium Oy, founded in 2015 in Tampere, Finland, specializes in advanced digital microscopy technology aimed at enhancing the field of diagnostic pathology. The company develops high-precision, smart, and portable digital microscope scanners that facilitate remote diagnostics in animal and human healthcare settings, as well as laboratory services. With innovative applications of cutting-edge mobile technology, Grundium’s solutions have the ability to improve both the reach and quality of diagnostic pathology, ultimately making high-quality scanning more accessible and cost-effective for local clinics and labs.
By leveraging advanced imaging capabilities, Grundium addresses a critical need within the healthcare industry, enabling pathologists to operate efficiently across multiple locations. Their products are designed for versatility, serving various microscopy fields, from routine pathology to artificial intelligence diagnosis.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
The healthcare technology sector in Finland has been witnessing substantial growth, driven by a strong focus on innovation and digitalization. As a country renowned for its commitment to high-quality healthcare, Finland is positioned as a hub for the developme
Similar Deals
Verso Capital and Armada Credit Partners → Suomen Avustajapalvelut
2025
Voima Ventures → Sooma Medical
2024
Verso Capital → Vetrospace
2023
Juuri Partners → Mediconsult Oy
2023
MB Rahastot → Spider Med Oy
2023
Nordic Secondary Fund II → Pixieray Oy
2023
EW Healthcare Partners
invested in
Grundium Oy
in 2023
in a Growth Equity & Expansion Capital deal